Inclusion of Telemedicine in Behavioral Health Quality Measures
OBJECTIVE: The authors evaluated available evidence to determine whether telemedicine services should be allowed in seven nationally reported behavioral health quality measures in the Healthcare Effectiveness Data and Information Set.
METHODS: The authors searched PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews for articles that met several inclusion criteria (relevant diagnosis and age, as specified in the quality measures). They also consulted expert panels on whether, and how, to include telemedicine in behavioral health measure specifications.
RESULTS: Thirty-two studies met the inclusion criteria. Their findings suggested that video conferencing, telephone calls, and web-based telemedicine modalities are as effective as in-person visits for diagnosis and management of most mental health and substance use disorders. Expert panels supported including telemedicine modalities in specific behavioral health measures.
CONCLUSIONS: Specific telemedicine modalities are effective, convenient ways to deliver behavioral health care. Revising quality measures to allow telemedicine services will support new methods for providing care.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Psychiatric services (Washington, D.C.) - 71(2020), 12 vom: 01. Dez., Seite 1288-1291 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liu, Junqing [VerfasserIn] |
---|
Links: |
---|
Themen: |
Diagnosis |
---|
Anmerkungen: |
Date Completed 28.07.2021 Date Revised 28.07.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1176/appi.ps.201900449 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316461253 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316461253 | ||
003 | DE-627 | ||
005 | 20231225161130.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1176/appi.ps.201900449 |2 doi | |
028 | 5 | 2 | |a pubmed24n1054.xml |
035 | |a (DE-627)NLM316461253 | ||
035 | |a (NLM)33076791 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liu, Junqing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inclusion of Telemedicine in Behavioral Health Quality Measures |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.07.2021 | ||
500 | |a Date Revised 28.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The authors evaluated available evidence to determine whether telemedicine services should be allowed in seven nationally reported behavioral health quality measures in the Healthcare Effectiveness Data and Information Set | ||
520 | |a METHODS: The authors searched PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews for articles that met several inclusion criteria (relevant diagnosis and age, as specified in the quality measures). They also consulted expert panels on whether, and how, to include telemedicine in behavioral health measure specifications | ||
520 | |a RESULTS: Thirty-two studies met the inclusion criteria. Their findings suggested that video conferencing, telephone calls, and web-based telemedicine modalities are as effective as in-person visits for diagnosis and management of most mental health and substance use disorders. Expert panels supported including telemedicine modalities in specific behavioral health measures | ||
520 | |a CONCLUSIONS: Specific telemedicine modalities are effective, convenient ways to deliver behavioral health care. Revising quality measures to allow telemedicine services will support new methods for providing care | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Telemedicine | |
650 | 4 | |a diagnosis | |
650 | 4 | |a mental health | |
650 | 4 | |a quality measurement | |
650 | 4 | |a substance use disorder | |
650 | 4 | |a treatment | |
700 | 1 | |a Obioha, Tochukwu |e verfasserin |4 aut | |
700 | 1 | |a Magpantay, Jenneil |e verfasserin |4 aut | |
700 | 1 | |a Kanovsky, Douglas |e verfasserin |4 aut | |
700 | 1 | |a Niles, Lauren |e verfasserin |4 aut | |
700 | 1 | |a Scholle, Sarah H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Psychiatric services (Washington, D.C.) |d 1998 |g 71(2020), 12 vom: 01. Dez., Seite 1288-1291 |w (DE-627)NLM075107546 |x 1557-9700 |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2020 |g number:12 |g day:01 |g month:12 |g pages:1288-1291 |
856 | 4 | 0 | |u http://dx.doi.org/10.1176/appi.ps.201900449 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2020 |e 12 |b 01 |c 12 |h 1288-1291 |